Il 6 Inhibitors Approved
SARS-CoV-2 Human IgG (4-Plex) Multiplex ELISA Kit (EUA Approved) |
||||||||||||||||||||||||||||||||||||||||||||||
| MEK2009-1 | BosterBio | 1 kit | EUR 1122 | |||||||||||||||||||||||||||||||||||||||||||
|
Description: Product Overview_x000D_The Q-Plex™ SARS-CoV-2 Human IgG (4-plex) Multiplex ELISA Kit is a qualitative chemiluminescent assay (ELISA) allowing concurrent measurement of human IgG antibodies to SARS-CoV-2 S1 and SARS-CoV-2 S2 proteins in serum and plasma samples. It has been authorized by FDA under a EUA for use by high complexity CLIA labs. Sensitive, reproducible, and convenient 96-well format requiring low sample volumes. Requires the Q-View™ Imaging System for analysis. _x000D__x000D_Assay Principle_x000D_The Q-Plex™ SARS-CoV-2 Human IgG (4-Plex) multiplex assay is a qualitative enzyme-linked immunosorbent assay that detects IgG antibodies to SARS-CoV-2 in human serum or plasma. SARS-CoV-2 is the novel coronavirus that causes COVID-19. The SARS-CoV-2 virus has several structural proteins including two spike proteins, S1 and S2. When an individual is infected with the SARS-CoV-2 virus, their immune system produces antibodies to these viral proteins. The typical immune response produces detectable antibody levels ~8-10 days following the onset of symptoms. _x000D__x000D_The Q-Plex SARS-CoV-2 Human IgG Quantitative (4-Plex) Multiplex ELISA detects IgG antibodies to both the S1 and S2 spike proteins present in a blood sample. If antibodies are detected, the result will be considered positive. If antibodies are not detected, the result will be considered negative. The assay only detects IgG antibodies, not other classes of antibodies such as IgM or IgA. _x000D__x000D_The multiplex assay allows for simultaneous indirect ELISA on the following four printed spots:;_x000D_
Assay Validation_x000D_The Q-Plex™ SARS-CoV-2 Human IgG (4-Plex) ELISA tests for IgG antibodies to either the SARS-CoV-2 S1 protein or the SARS-CoV-2 S2 protein. Our validation studies identified measurable improvement in clinical performance when results from the S1 and S2 assays are considered together rather than single assays (see assay validation data below). Quansys recommends that a sample should only be considered positive for the presence of SARS-CoV-2 reactive IgGs when antibodies reactive to both S1 and S2 are detected. _x000D_Negative samples, collected prior to August 2019, and known positive samples collected from individuals who tested positive for COVID-19 on a molecular test at least 14 days prior to sample collection were used to determine clinical sensitivity and specificity. _x000D_Evaluating the S1 and S2 simultaneously allows for greater clinical sensitivity and specificity. _x000D_
Kit Components_x000D_Each kit contains a 96-well plate, featuring the relevant biomarker panel in each well, and all reagents required to perform testing. _x000D_Reagents include: _x000D_Wash Buffer Concentrate (20X): Liquid, 50 mL/vial of a concentrated solution of buffered surfactant;_x000D_Sample Diluent (2X): Liquid, 10 mL/vial of a concentrated buffered protein solution with preservatives;_x000D_Detection Mix: Liquid, 6 mL/vial of biotinylated antibodies in a buffered protein solution with preservatives;_x000D_Calibrators (High, Low, Negative): Lyophilized, human serum diluted in a buffered protein base;_x000D_Streptavidin-HRP (1X): Liquid, 6 mL/vial of streptavidin-conjugated horseradish peroxidase;_x000D_Substrate A: Liquid, 3 mL/vial of peroxide solution;_x000D_Substrate B+: Liquid, 3 mL/vial of luminol solution;_x000D_Plate Seals (3): Adhesive strips _x000D__x000D_Kit Processing_x000D_The Multiplex assays require the use of the Q-View™ software to read and interpret the test results. A fully-functional, free trial version of the software is available to download, install, and use to analyze your first kit (s). At the end of the trial period, a purchased license is required to continue the use of the Q-View software. _x000D_Q-Plex arrays are developed and optimized to work with Q-View imagers. We do not guarantee the results obtained from other imagers because not all imagers are compatible with Q-Plex arrays. |
||||||||||||||||||||||||||||||||||||||||||||||
Human IgG antibody Laboratories manufactures the il 6 inhibitors approved reagents distributed by Genprice. The Il 6 Inhibitors Approved reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact il 6 elisa. Other Il products are available in stock. Specificity: Il Category: 6 Group: Inhibitors Approved
DiscoveryProbe? FDA-approved Drug Library |
||
| ApexBio | 50 uL/well(10 mM solution) | EUR 4514.4 |
|
Description: DiscoveryProbe? FDA-approved drug library includes 1496 FDA approved drugs for high throughput screening (HTS) and high content screening (HCS). It can be used to find new targets for old drugs. The bioactivity and safety of these drugs were confirmed by clinical trials. |
||
DiscoveryProbe? FDA-approved Drug Library |
||
| ApexBio | 5 mg/well | EUR 15789.6 |
|
Description: DiscoveryProbe? FDA-approved drug library includes 1496 FDA approved drugs for high throughput screening (HTS) and high content screening (HCS). It can be used to find new targets for old drugs. The bioactivity and safety of these drugs were confirmed by clinical trials. |
||
Human True Insulin ELISA Kit |
||
| MyBiosource | 10x96-Strip-Wells | EUR 6725 |
Human True Insulin ELISA Kit |
||
| MyBiosource | 48-Strip-Wells | EUR 550 |
Human True Insulin ELISA Kit |
||
| MyBiosource | 5x96-Strip-Wells | EUR 3420 |
Human True Insulin ELISA Kit |
||
| MyBiosource | 96-Strip-Wells | EUR 765 |
Human True Insulin GENLISA ELISA |
||
| Krishgen | 1 x 96 wells | EUR 286 |
Inhibitors Approved information
Fetal Bovine Serum (Chile. USDA approved). Heat Inactivated - 500ml |
|||
| FB-1365H/500 | Biosera France - Medical Scientific Equipment | 500ml | EUR 198.61 |
Fetal Bovine Serum (Mexico. USDA approved). Heat Inactivated - 500ml |
|||
| FB-1360H/500 | Biosera France - Medical Scientific Equipment | 500ml | EUR 235.29 |
SARS-CoV-2 Human IgG (4-Plex) Multiplex ELISA Kit (EUA Approved) |
||||||||||||||||||||||||||||||||||||||||||||||
| MEK2009-1 | BosterBio | 1 kit | EUR 1122 | |||||||||||||||||||||||||||||||||||||||||||
|
Description: Product Overview_x000D_The Q-Plex™ SARS-CoV-2 Human IgG (4-plex) Multiplex ELISA Kit is a qualitative chemiluminescent assay (ELISA) allowing concurrent measurement of human IgG antibodies to SARS-CoV-2 S1 and SARS-CoV-2 S2 proteins in serum and plasma samples. It has been authorized by FDA under a EUA for use by high complexity CLIA labs. Sensitive, reproducible, and convenient 96-well format requiring low sample volumes. Requires the Q-View™ Imaging System for analysis. _x000D__x000D_Assay Principle_x000D_The Q-Plex™ SARS-CoV-2 Human IgG (4-Plex) multiplex assay is a qualitative enzyme-linked immunosorbent assay that detects IgG antibodies to SARS-CoV-2 in human serum or plasma. SARS-CoV-2 is the novel coronavirus that causes COVID-19. The SARS-CoV-2 virus has several structural proteins including two spike proteins, S1 and S2. When an individual is infected with the SARS-CoV-2 virus, their immune system produces antibodies to these viral proteins. The typical immune response produces detectable antibody levels ~8-10 days following the onset of symptoms. _x000D__x000D_The Q-Plex SARS-CoV-2 Human IgG Quantitative (4-Plex) Multiplex ELISA detects IgG antibodies to both the S1 and S2 spike proteins present in a blood sample. If antibodies are detected, the result will be considered positive. If antibodies are not detected, the result will be considered negative. The assay only detects IgG antibodies, not other classes of antibodies such as IgM or IgA. _x000D__x000D_The multiplex assay allows for simultaneous indirect ELISA on the following four printed spots:;_x000D_
Assay Validation_x000D_The Q-Plex™ SARS-CoV-2 Human IgG (4-Plex) ELISA tests for IgG antibodies to either the SARS-CoV-2 S1 protein or the SARS-CoV-2 S2 protein. Our validation studies identified measurable improvement in clinical performance when results from the S1 and S2 assays are considered together rather than single assays (see assay validation data below). Quansys recommends that a sample should only be considered positive for the presence of SARS-CoV-2 reactive IgGs when antibodies reactive to both S1 and S2 are detected. _x000D_Negative samples, collected prior to August 2019, and known positive samples collected from individuals who tested positive for COVID-19 on a molecular test at least 14 days prior to sample collection were used to determine clinical sensitivity and specificity. _x000D_Evaluating the S1 and S2 simultaneously allows for greater clinical sensitivity and specificity. _x000D_
Kit Components_x000D_Each kit contains a 96-well plate, featuring the relevant biomarker panel in each well, and all reagents required to perform testing. _x000D_Reagents include: _x000D_Wash Buffer Concentrate (20X): Liquid, 50 mL/vial of a concentrated solution of buffered surfactant;_x000D_Sample Diluent (2X): Liquid, 10 mL/vial of a concentrated buffered protein solution with preservatives;_x000D_Detection Mix: Liquid, 6 mL/vial of biotinylated antibodies in a buffered protein solution with preservatives;_x000D_Calibrators (High, Low, Negative): Lyophilized, human serum diluted in a buffered protein base;_x000D_Streptavidin-HRP (1X): Liquid, 6 mL/vial of streptavidin-conjugated horseradish peroxidase;_x000D_Substrate A: Liquid, 3 mL/vial of peroxide solution;_x000D_Substrate B+: Liquid, 3 mL/vial of luminol solution;_x000D_Plate Seals (3): Adhesive strips _x000D__x000D_Kit Processing_x000D_The Multiplex assays require the use of the Q-View™ software to read and interpret the test results. A fully-functional, free trial version of the software is available to download, install, and use to analyze your first kit (s). At the end of the trial period, a purchased license is required to continue the use of the Q-View software. _x000D_Q-Plex arrays are developed and optimized to work with Q-View imagers. We do not guarantee the results obtained from other imagers because not all imagers are compatible with Q-Plex arrays. |
||||||||||||||||||||||||||||||||||||||||||||||
Fetal Bovine Serum (Central America. USDA approved). Heat Inactivated - 100ml |
|||
| FB-1345H/100 | Biosera France - Medical Scientific Equipment | 100ml | EUR 53.79 |
Fetal Bovine Serum (Central America. USDA approved). Heat Inactivated - 500ml |
|||
| FB-1345H/500 | Biosera France - Medical Scientific Equipment | 500ml | EUR 235.29 |
FBS - Heat Inactivated Premium Imported Fetal Bovine Serum (USDA Approved) |
|||
| FBS002-HI | Neuromics | each | EUR 302.4 |
FBS - Heat Inactivated Qualified Imported Fetal Bovine Serum (USDA Approved) |
|||
| FBS006-HI | Neuromics | each | EUR 279 |
FBS-Heat Inactivated Premium Imported Fetal Bovine Serum (USDA Approved) |
|||
| MBS555989-500mL | MyBiosource | 500mL | EUR 485 |
FBS-Heat Inactivated Premium Imported Fetal Bovine Serum (USDA Approved) |
|||
| MBS555989-5x500mL | MyBiosource | 5x500mL | EUR 2040 |
FBS-Heat Inactivated Standard Imported Fetal Bovine Serum (USDA Approved) |
|||
| MBS555993-500mL | MyBiosource | 500mL | EUR 425 |
FBS-Heat Inactivated Standard Imported Fetal Bovine Serum (USDA Approved) |
|||
| MBS555993-5x500mL | MyBiosource | 5x500mL | EUR 1760 |
FBS-Heat Inactivated Qualified Imported Fetal Bovine Serum (USDA Approved) |
|||
| MBS555998-500mL | MyBiosource | 500mL | EUR 385 |
FBS-Heat Inactivated Qualified Imported Fetal Bovine Serum (USDA Approved) |
|||
| MBS555998-5x500mL | MyBiosource | 5x500mL | EUR 1590 |
Protease inhibitors Mix of 6 inhibitors (100X) |
|||
| PRI51-1 | Alpha Diagnostics | 1 ml | EUR 196.8 |
Tankyrase Inhibitors (TNKS) 22 |
|||
| A8600-10 | ApexBio | 10 mg | EUR 280 |
|
Description: Chromatin/Epigenetics|PARP#DNA Damage/DNA Repair|PARP#Stem Cell|Wnt/β-catenin |
|||
Tankyrase Inhibitors (TNKS) 22 |
|||
| A8600-100 | ApexBio | 100 mg | EUR 1200 |
|
Description: Chromatin/Epigenetics|PARP#DNA Damage/DNA Repair|PARP#Stem Cell|Wnt/β-catenin |
|||
Tankyrase Inhibitors (TNKS) 22 |
|||
| A8600-5 | ApexBio | 5 mg | EUR 160 |
|
Description: Chromatin/Epigenetics|PARP#DNA Damage/DNA Repair|PARP#Stem Cell|Wnt/β-catenin |
|||
